Skip to main content

$0.205 (0.00%)

High

-

Low

-

Trades

-

Turnover

$0

Volume

0
3 July 2025 at 10:27pm
Register to track RAP and receive email alerts.

ResApp announces FDA 510(k) submission for SleepCheckRx

StockBot

416,823 posts

RAP released this announcement to the ASX on 11 October 2021, 9:19. The announcement is marked as price sensitive, and is 2 page(s) in length and 120.85kb in size.

You can view all announcements from RAP and see how they appear on a price chart on the announcements page.

At the date of this announcement, RAP was 0.185% short sold according to ASIC data. It was ranked the 407th most shorted stock on the ASX. It remains ranked 573rd as of the latest reported data (21 September 2022).

Other Recent Announcements from RAP
Removal from Official List 27 September 2022, 11:58
Scheme of Arrangement has been Implemented 26 September 2022, 16:28
Ceasing to be a substantial holder 20 September 2022, 8:09
ResApp announces FDA 510(k) submission for SleepCheckRx 11 October 2021, 9:19
Notification regarding unquoted securities - RAP 1 October 2021, 17:44
Notification of cessation of securities - RAP 1 October 2021, 17:36
Change of Share Registry 1 October 2021, 8:44
You must login or register to post a comment.

You must be logged in to post a reply.

Register to track RAP and receive email alerts.